Effettua una ricerca
NEW GLUTEN WORLD S.R.L.
Acronimo
NGW
Partita Iva
00028460475
Codice ATECO
77.40.00
ATTIVITÀ DI NOLEGGIO E LEASING OPERATIVO
Data di costituzione
09/04/2015
Descrizione sintetica dell'oggetto sociale
La Società ha per oggetto (i) l’attività di industrializzazione del processo di de-tossificazione delle proteine dei cereali di cui alla domanda di brevetto dal titolo “Metodo per la detossificazione delle proteine del glutine dalla granella di cereali”, di cui alla domanda di brevetto n. RM2012A000468 concessa in Italia il 26/03/2015 con n. 0001414717 e relativa domanda di estensione PCT n. PCT/IB2013/000797 dal titolo “Method for the detoxification of gluten proteins from grains of cereals” e sue integrazioni ed evoluzioni (di seguito il “Trovato”) e (ii) l’attività di sfruttamento economico, tramite sub-licenze, del Trovato e del know-how in materia di detossificazione del glutine, ricevuto anche tramite licenza, da UNIFG. Al fine esclusivo di realizzare l’oggetto sociale e, peraltro, quale attività non prevalente, la Società potrà compiere tutte le operazioni commerciali, industriali, finanziarie, mobiliari e immobiliari ritenute necessarie od utili.
'Led by inventor Carmen Lamacchia, New Gluten World (NGW) is a company that aims at bringing on the market its revolutionary proprietary technology that will be used in milling processes to detoxify gluten in wheat. The traditional approach to celiac disease that is, a gluten free diet or detoxified gluten with expensive enzymes will be replaced by a new, disruptive and cost-effective approach, where a natural and safe physic-chemical process modifies the toxic component of gluten, while leaving its mechanical, nutritional, and sensorial properties. Celiac, intolerant, and glutensensitive patients will have the chance of a new lifestyle, without suffering the nutritional divide with respect to healthy individuals. The methodology stems from the advanced biotech research conducted at the University of Foggia and addresses a grand social and economic challenge for Europe and for the world, where celiac patients are on average 1% of the world population, while 30% has gluten-sensitivity, with figures increasing every year. Thanks to a strong team, with industrial and technological expertise, NGW will enable milling companies (mostly SMEs) in Europe and abroad to adopt the process technology and related know-how, thus reinforcing the well-known leadership of the European agro-food industry in terms of quality, as opposed to intensive productions by other economic systems. The market opportunity is huge, fenced by a patent extended in 104 countries. Such opportunity will be seized by NGW moving from TRL #6 to TRL #8 and #9 in a 24-month time-span. Aiming to become the market leader for industrial processes in detoxifying gluten in cereals for all markets (backed products, pasta, ice-creams, beer), NGW plans to reach a turnover of over 100M by 2022, with an ambitious hiring plan of qualified workers in Europe. NGW received the prestigious NutriAward (2015) and a manifestation of interest from a leading European venture capital firm that will support its growth.'
Condividi questo sito sui social